Literature DB >> 25997302

Consensus document on allergic conjunctivitis (DECA).

M C Sánchez-Hernández, J Montero, C Rondon, J M Benitez del Castillo, E Velázquez, J M Herreras, B Fernández-Parra, J Merayo-Lloves, A Del Cuvillo, F Vega, A Valero, C Panizo, J Montoro, V Matheu, M Lluch-Bernal, M L González, R González, M T Dordal, I Dávila, C Colás, P Campo, E Antón, A Navarro.   

Abstract

Allergic conjunctivitis (AC) is an inflammatory disease of the conjunctiva caused mainly by an IgE-mediated mechanism. It is the most common type of ocular allergy. Despite being the most benign form of conjunctivitis, AC has a considerable effect on patient quality of life, reduces work productivity, and increases health care costs. No consensus has been reached on its classification, diagnosis, or treatment. Consequently, the literature provides little information on its natural history, epidemiological data are scarce, and it is often difficult to ascertain its true morbidity. The main objective of the Consensus Document on Allergic Conjunctivitis (Documento dE Consenso sobre Conjuntivitis Alérgica [DECA]), which was drafted by an expert panel from the Spanish Society of Allergology and Spanish Society of Ophthalmology, was to reach agreement on basic criteria that could prove useful for both specialists and primary care physicians and facilitate the diagnosis, classification, and treatment of AC. This document is the first of its kind to describe and analyze aspects of AC that could make it possible to control symptoms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25997302

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  6 in total

1.  Validation of the DECA criteria for allergic conjunctivitis severity and control.

Authors:  M Cesárea Sánchez-Hernández; Ana M Navarro; Joaquim Mullol; Antonio Valero; Carlos Colás; Alfonso Del Cuvillo; Joaquín Sastre
Journal:  Clin Transl Allergy       Date:  2020-10-23       Impact factor: 5.871

Review 2.  Therapeutic Targets in Allergic Conjunctivitis.

Authors:  Bisant A Labib; DeGaulle I Chigbu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-28

Review 3.  Child with Allergies or Allergic Reactions.

Authors:  Reshma A; Arun K Baranwal
Journal:  Indian J Pediatr       Date:  2017-09-11       Impact factor: 1.967

Review 4.  [Seasonal allergic conjunctivitis].

Authors:  K Schröder; D Finis; S Meller; M Wagenmann; G Geerling; U Pleyer
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

Review 5.  Allergic conjunctivitis in Asia.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2017-04-12

6.  Involvement of transient receptor potential channels in ocular diseases: a narrative review.

Authors:  Tian-Jing Yang; Yang Yu; Jing-Yi Yang; Jin-Jing Li; Jun-Ya Zhu; João Alexandre Cardoso Vieira; Qin Jiang
Journal:  Ann Transl Med       Date:  2022-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.